Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP268065.RAKhjaDwx6wI30ZES8z19MMiURfvdJCcwR184x60VR-hU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP268065.RAKhjaDwx6wI30ZES8z19MMiURfvdJCcwR184x60VR-hU130_assertion type Assertion NP268065.RAKhjaDwx6wI30ZES8z19MMiURfvdJCcwR184x60VR-hU130_head.
- NP268065.RAKhjaDwx6wI30ZES8z19MMiURfvdJCcwR184x60VR-hU130_assertion description "[We conclude that among the SRCTs, MIC2 expression is not limited to Ewing's sarcoma and primitive neuroectodermal tumors, but also shows strong and reliable expression in lymphoblastic lymphomas and related leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP268065.RAKhjaDwx6wI30ZES8z19MMiURfvdJCcwR184x60VR-hU130_provenance.
- NP268065.RAKhjaDwx6wI30ZES8z19MMiURfvdJCcwR184x60VR-hU130_assertion evidence source_evidence_literature NP268065.RAKhjaDwx6wI30ZES8z19MMiURfvdJCcwR184x60VR-hU130_provenance.
- NP268065.RAKhjaDwx6wI30ZES8z19MMiURfvdJCcwR184x60VR-hU130_assertion SIO_000772 8163272 NP268065.RAKhjaDwx6wI30ZES8z19MMiURfvdJCcwR184x60VR-hU130_provenance.
- NP268065.RAKhjaDwx6wI30ZES8z19MMiURfvdJCcwR184x60VR-hU130_assertion wasDerivedFrom befree-20140225 NP268065.RAKhjaDwx6wI30ZES8z19MMiURfvdJCcwR184x60VR-hU130_provenance.
- NP268065.RAKhjaDwx6wI30ZES8z19MMiURfvdJCcwR184x60VR-hU130_assertion wasGeneratedBy ECO_0000203 NP268065.RAKhjaDwx6wI30ZES8z19MMiURfvdJCcwR184x60VR-hU130_provenance.